Nymox Pharmaceutical Corporation (NYMXF)
USD 0.14
(-8.36%)
USD 0.14
(-8.36%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.8 Million USD | 80.35% |
| 2022 | 2.1 Million USD | 8.11% |
| 2021 | 1.94 Million USD | -11.33% |
| 2020 | 2.19 Million USD | 7.69% |
| 2019 | 2.04 Million USD | 90.04% |
| 2018 | 1.07 Million USD | -51.84% |
| 2017 | 2.23 Million USD | -3.0% |
| 2016 | 2.29 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 FY | 3.8 Million USD | 80.35% |
| 2023 Q4 | 3.8 Million USD | 47.8% |
| 2023 Q3 | 2.57 Million USD | -18.33% |
| 2023 Q2 | 3.14 Million USD | 32.6% |
| 2023 Q1 | 2.37 Million USD | 12.67% |
| 2022 Q1 | 2.62 Million USD | 34.84% |
| 2022 Q4 | 2.1 Million USD | -11.02% |
| 2022 Q3 | 2.36 Million USD | 5.62% |
| 2022 Q2 | 2.24 Million USD | -14.69% |
| 2021 Q4 | 1.94 Million USD | -14.07% |
| 2021 Q3 | 2.26 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -13751.93% |
| Arch Therapeutics, Inc. | 9.46 Million USD | 59.856% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 94.757% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -369.835% |
| Rebus Holdings, Inc. | 5.24 Million USD | 27.509% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 93.561% |
| Qrons Inc. | 1.48 Million USD | -155.254% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 1.22 Million USD | -209.897% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 94.928% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -8401.879% |
| Skye Bioscience, Inc. | 14.07 Million USD | 72.996% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 92.871% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | 60.342% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -801.397% |
| SQZ Biotechnologies Company | 50.03 Million USD | 92.406% |
| Intellipharmaceutics International Inc. | 12 Million USD | 68.356% |
| Propanc Biopharma, Inc. | 3.85 Million USD | 1.335% |
| Mesoblast Limited | 188.44 Million USD | 97.983% |
| Marizyme, Inc. | 26.67 Million USD | 85.755% |
| Genus plc | 485 Million USD | 99.216% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | 34.961% |
| Pharming Group N.V. | 244.07 Million USD | 98.443% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -89.042% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -51.014% |
| ContraFect Corporation | 32.53 Million USD | 88.319% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -91.792% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | 0.722% |
| IMV Inc. | 37.93 Million USD | 89.982% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | 67.737% |
| MultiCell Technologies, Inc. | 1617.67 USD | -234805.76% |
| ONE Bio Corp. | 27.49 Million USD | 86.18% |
| Accustem Sciences Inc. | 1.07 Million USD | -252.1% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 95.092% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -79.663% |
| Q BioMed Inc. | 8.13 Million USD | 53.276% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 95.418% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | 26.157% |
| Biomind Labs Inc. | 1.49 Million USD | -153.568% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 96.799% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | 57.975% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | 79.352% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -165.019% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -2574.267% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -1789.457% |
| Curative Biotechnology, Inc. | 5.74 Million USD | 33.865% |
| GB Sciences, Inc. | 5.41 Million USD | 29.858% |
| Alpha Cognition Inc. | 7.16 Million USD | 46.963% |
| HST Global, Inc. | 593.59 Thousand USD | -540.169% |
| CSL Limited | 18.62 Billion USD | 99.98% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -201.781% |
| Halberd Corporation | 728.71 Thousand USD | -421.463% |
| Enzolytics Inc. | 365.26 Million USD | 98.96% |
| Agentix Corp. | 2.51 Million USD | -51.361% |
| Resverlogix Corp. | 67.39 Million USD | 94.362% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -353.065% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 99.146% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -121.704% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | 84.644% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | 68.076% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -3.679% |
| AVAX Technologies, Inc. | 3.99 Million USD | 4.851% |
| Zenith Capital Corp. | 27.56 Thousand USD | -13683.598% |
| Genscript Biotech Corporation | 1.32 Billion USD | 99.713% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -1492.263% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -1.759% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -458.139% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -40.137% |
| Kadimastem Ltd | 3.5 Million USD | -8.421% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -5577.658% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 92.44% |
| BioStem Technologies, Inc. | 15.9 Million USD | 76.108% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -717.734% |
| LadRx Corporation | 2.2 Million USD | -72.686% |
| Cell Source, Inc. | 15.8 Million USD | 75.96% |
| Regen BioPharma, Inc. | 5.45 Million USD | 30.373% |
| Regen BioPharma, Inc. | 5.45 Million USD | 30.373% |
| NovAccess Global Inc. | 7.86 Million USD | 51.658% |
| Affymax, Inc. | 8.87 Million USD | 57.164% |
| Itoco Inc. | 1.65 Million USD | -129.864% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -85.224% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | 37.18% |
| Mobile Lads Corp. | 1.31 Million USD | -189.304% |
| CytoDyn Inc. | 127.89 Million USD | 97.029% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -8991.127% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -142.598% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | 65.596% |
| SYBLEU INC | 681.41 Thousand USD | -457.665% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | 37.724% |
| International Stem Cell Corporation | 5.27 Million USD | 27.989% |
| Bioxytran, Inc. | 3.24 Million USD | -16.941% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -507.214% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | 17.698% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 90.731% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | 82.933% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -87.618% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | 30.632% |
| Neutra Corp. | 973.52 Thousand USD | -290.332% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | 86.903% |
| PureTech Health plc | 125.58 Million USD | 96.974% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -1.141% |
| IXICO plc | 1.9 Million USD | -99.969% |
| IntelGenx Technologies Corp. | 20.52 Million USD | 81.49% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 96.322% |
| CSL Limited | 18.62 Billion USD | 99.98% |
| Cellectis S.A. | 249.36 Million USD | 98.476% |